Cas no 826-36-8 (Triacetonamine)
Triacetonamine Chemical and Physical Properties
Names and Identifiers
-
- 2,2,6,6-Tetramethylpiperidin-4-one
- 2,2,6,6-Tetramethyl-4-oxopiperidine
- 2,2,6,6-Tetramethyl-4-piperidinone
- Triacetonamin
- Triacetonamine
- Vincubine
- 2,2,6,6-Tetramethyl-4-piperidone
- 2,2,6,6-Tetramethyl-
- Tetramethylpiperidinone
- 2,2,6,6-tetramethyl-4-oxo-piperidine
- 2,2,6,6-tetramethyl-piperidinyl-4-one
- 4-oxo-2,2,6,6-tetramethylpiperidine
- IKh196
- Odoratine
- TEMP
- Tempidon
- triacetone amine
- Vincubina
- NSC 16579
- [ "2", "2", "6", "6-Tetramethyl-4-piperidinone" ]
- Triacetoneamine
- IKh 196
- 2
- 4-Piperidinone, 2,2,6,6-tetramethyl-
- Trojacetonoaminy
- 2,2,6,6-Tetramethylpiperidone
- 2,2,6,6-Tetramethylpiperidinone
- Trojacetonoaminy [Polish]
- TMPone
- 2,2,6,6-Tetramethyl-piperidin-4-one
- 4-Oxo-2,2,6,6-
- 2,2,6,6-Tetramethyl-4-piperidinone (ACI)
- 4-Piperidone, 2,2,6,6-tetramethyl- (6CI, 7CI, 8CI)
- Tetramethylpiperidone
- Violine
- CAS-826-36-8
- UNII-2K4430S3XP
- NSC-16579
- AKOS000120903
- CS-0016419
- CHEMBL117614
- IKH-19
- CHEBI:177813
- 4-OXO-2,2,6,6-TETRAMETHYLPIPERIDINE (D17, 15N)
- 2,2,6,6-Tetramethyl-g-piperidone
- Tox21_300816
- MFCD00005975
- 2,2,6,6-teramethyl-4-piperidone
- 2,2,6,6-tetramethylpiperidone-4-toluene-p- sulfonate
- S4859
- NCGC00248182-01
- 2K4430S3XP
- NSC16579
- SB74533
- 2,2,6, 6-Tetramethyl-4-piperidinone
- TO0127900
- BRN 0112665
- NCGC00254720-01
- Odoratin?
- 5-21-06-00538 (Beilstein Handbook Reference)
- AC-2702
- HY-N1131
- SCHEMBL38953
- 826-36-8
- CCG-44306
- Z1250100692
- P19976
- EINECS 212-554-2
- T1424
- Oprea1_386573
- 4-Oxo-2,2,6,6-tetramethyl-4-piperidone
- EC 212-554-2
- SR-01000634150-1
- DTXSID4041527
- 4-PIPERIDONE, 2,2,6,6-TETRAMETHYL-
- InChI=1/C9H17NO/c1-8(2)5-7(11)6-9(3,4)10-8/h10H,5-6H2,1-4H3
- STR06804
- 2,6,6-Tetramethyl-4-piperidinone
- 2,6,6-Tetramethyl-4-oxopiperidine
- NCGC00248182-02
- 2,6,6-Tetramethyl-4-piperidone
- AB00375601-03
- NS00008501
- W-104169
- EN300-18105
- Q6120732
- F8889-5387
- 2,2,6,6-Tetramethyl-4-piperidone, 95%
- JWUXJYZVKZKLTJ-UHFFFAOYSA-
- FT-0609128
- DTXCID2021527
- piperidine, 2,2,6,6-tetramethyl-4-oxo-
- STK256617
- DA-60001
- 2,2,6,6-Tetramethyl-4 piperidone
-
- MDL: MFCD00005975
- Inchi: 1S/C9H17NO/c1-8(2)5-7(11)6-9(3,4)10-8/h10H,5-6H2,1-4H3
- InChI Key: JWUXJYZVKZKLTJ-UHFFFAOYSA-N
- SMILES: O=C1CC(C)(C)NC(C)(C)C1
Computed Properties
- Exact Mass: 155.13100
- Monoisotopic Mass: 155.131
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 1
- Hydrogen Bond Acceptor Count: 2
- Heavy Atom Count: 11
- Rotatable Bond Count: 0
- Complexity: 164
- Covalently-Bonded Unit Count: 1
- Defined Atom Stereocenter Count: 0
- Undefined Atom Stereocenter Count : 0
- Defined Bond Stereocenter Count: 0
- Undefined Bond Stereocenter Count: 0
- Surface Charge: 0
- Tautomer Count: 2
- XLogP3: 0.5
- Topological Polar Surface Area: 29.1
Experimental Properties
- Color/Form: Powder
- Density: 0.9796 (rough estimate)
- Melting Point: 38.0 to 42.0 deg-C
- Boiling Point: 102-105?°C/18?mmHg(lit.)
- Flash Point: Fahrenheit: 163.4 ° f < br / > Celsius: 73 ° C < br / >
- Refractive Index: 1.4680 (estimate)
- PSA: 29.10000
- LogP: 1.82490
- Sensitiveness: Sensitive to heat, air and light
- Solubility: Soluble in acetone, alcohol, ether and water.
Triacetonamine Security Information
-
Symbol:
- Prompt:warning
- Signal Word:Warning
- Hazard Statement: H302-H315-H319
- Warning Statement: P264-P270-P280-P301+P312+P330-P302+P352+P332+P313+P362+P364-P305+P351+P338+P337+P313-P501
- Hazardous Material transportation number:NONH for all modes of transport
- WGK Germany:2
- Hazard Category Code: 22-36/37/38
- Safety Instruction: S45-S36/37/39-S26-S22-S36/37
- RTECS:TO0127900
-
Hazardous Material Identification:
- Risk Phrases:R22
- Storage Condition:0-10°C
Triacetonamine Customs Data
- HS CODE:2933399090
- Customs Data:
China Customs Code:
2933399090Overview:
2933399090. Other compounds with non fused pyridine rings in structure. VAT:17.0%. Tax refund rate:13.0%. Regulatory conditions:nothing. MFN tariff:6.5%. general tariff:20.0%
Declaration elements:
Product Name, component content, use to, Please indicate the appearance of Urotropine, 6- caprolactam please indicate the appearance, Signing date
Summary:
2933399090. other compounds containing an unfused pyridine ring (whether or not hydrogenated) in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0%
Triacetonamine Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| SHANG HAI MAI KE LIN SHENG HUA Technology Co., Ltd. | T830770-500g |
Triacetonamine |
826-36-8 | 98% | 500g |
558.00 | 2021-05-17 | |
| XI GE MA AO DE LI QI ( SHANG HAI ) MAO YI Co., Ltd. | 459119-100G |
Triacetonamine |
826-36-8 | 100g |
¥785.18 | 2024-05-11 | ||
| XI GE MA AO DE LI QI ( SHANG HAI ) MAO YI Co., Ltd. | 459119-500G |
Triacetonamine |
826-36-8 | 500g |
¥1118.7 | 2024-05-11 | ||
| Chemenu | CM180302-500g |
2,2,6,6-Tetramethylpiperidin-4-one |
826-36-8 | 97% | 500g |
$127 | 2021-08-05 | |
| SHANG HAI TAO SHU Biotechnology Co., Ltd. | T5543-500 mg |
TriacetonaMine |
826-36-8 | 98.00% | 500MG |
¥480.00 | 2022-04-26 | |
| ChemScence | CS-0016419-500g |
Triacetonamine |
826-36-8 | 99.88% | 500g |
$67.0 | 2022-04-26 | |
| ChemScence | CS-0016419-1000g |
Triacetonamine |
826-36-8 | ≥98.0% | 1000g |
$114.0 | 2021-09-02 | |
| SHANG HAI JI ZHI SHENG HUA Technology Co., Ltd. | T36931-25g |
Triacetonamine |
826-36-8 | 97% | 25g |
¥25.0 | 2024-07-18 | |
| SHANG HAI JI ZHI SHENG HUA Technology Co., Ltd. | T36931-5g |
Triacetonamine |
826-36-8 | 97% | 5g |
¥19.0 | 2024-07-18 | |
| SHANG HAI JI ZHI SHENG HUA Technology Co., Ltd. | T36931-500g |
Triacetonamine |
826-36-8 | 97% | 500g |
¥136.0 | 2024-07-18 |
Triacetonamine Production Method
Production Method 1
Production Method 2
Production Method 3
Production Method 4
Production Method 5
Production Method 6
Production Method 7
Production Method 8
1.2 Reagents: Hydrochloric acid Solvents: Water ; acidified, rt
1.3 Reagents: Potassium hydroxide Solvents: Water ; basified, rt
Production Method 9
Production Method 10
Production Method 11
Production Method 12
Production Method 13
1.2 Catalysts: Iron acetate
Production Method 14
1.2 Reagents: Sulfuric acid , Potassium sulfate
1.3 Reagents: Sodium hydroxide
Production Method 15
Production Method 16
Production Method 17
Production Method 18
Production Method 19
2.1 Reagents: Oxygen ; 1 atm, 298 K
Production Method 20
Triacetonamine Raw materials
- 2,2,6,6-tetramethylpiperidin-4-ol
- 1,2,2,6,6-Pentamethyl-4-piperidone
- Morpholine, 4-(1,2,3,6-tetrahydro-2,2,6,6-tetramethyl-4-pyridinyl)-
- 2,6-dimethylhepta-2,5-dien-4-one
- Pyrimidine,1,2,5,6-tetrahydro-2,2,4,6,6-pentamethyl-
- propan-2-imine
- 4-Amino-4-methyl-2-pentanone
Triacetonamine Preparation Products
Triacetonamine Suppliers
Triacetonamine Related Literature
-
Manickam Bakthadoss,Tadiparthi Thirupathi Reddy,Vishal Agarwal,Duddu S. Sharada Chem. Commun., 2022,58, 1406-1409
-
Gaurav J. Shah,Eric P.-Y. Chiou,Ming C. Wu,Chang-Jin “CJ” Kim Lab Chip, 2009,9, 1732-1739
-
Erika A. Cobar,Paul R. Horn,Robert G. Bergman,Martin Head-Gordon Phys. Chem. Chem. Phys., 2012,14, 15328-15339
-
Chung-Sung Yang,Mong-Shian Shih,Fang-Yi Chang New J. Chem., 2006,30, 729-735
-
Tengfei Yu,Yuehan Wu,Wei Li,Bin Li RSC Adv., 2014,4, 34134-34143
Additional information on Triacetonamine
Triacetonamine (CAS No. 826-36-8): A Comprehensive Overview of Its Applications and Recent Research Developments
Triacetonamine, with the chemical formula C?H??NO, is a significant compound in the field of organic chemistry and pharmaceutical research. Its CAS number, 826-36-8, uniquely identifies it in scientific literature and industrial applications. This compound has garnered considerable attention due to its versatile reactivity and its role as a precursor in the synthesis of various pharmacologically active molecules.
The structural framework of Triacetonamine consists of an acetyl group attached to a secondary amine, making it a valuable intermediate in the formation of more complex molecules. This unique structure allows it to participate in a wide range of chemical reactions, including nucleophilic additions, condensations, and reductions, which are pivotal in drug development.
In recent years, Triacetonamine has been extensively studied for its potential applications in medicinal chemistry. One of the most notable areas of research involves its use as a building block in the synthesis of antibiotics and antiviral agents. The compound's ability to undergo facile functionalization makes it an attractive candidate for modifying existing drug molecules or creating novel therapeutic agents.
A particularly intriguing aspect of Triacetonamine is its role in the development of protease inhibitors. Proteases are enzymes that play crucial roles in various biological processes, including virus replication and inflammation. By inhibiting specific proteases, Triacetonamine-derived compounds have shown promise in treating conditions such as HIV/AIDS and certain types of cancer. Recent studies have highlighted its efficacy in targeting viral proteases, thereby preventing the maturation of viral particles and reducing viral load in infected individuals.
Moreover, Triacetonamine has found applications in the field of materials science. Its derivatives exhibit interesting properties that make them suitable for use as catalysts and ligands in organic synthesis. For instance, certain complexes formed with transition metals have demonstrated enhanced catalytic activity in cross-coupling reactions, which are fundamental to constructing complex organic molecules.
The pharmaceutical industry has also explored the use of Triacetonamine in the development of central nervous system (CNS) drugs. Its structural motif is reminiscent of several neuroactive compounds, suggesting potential interactions with neurotransmitter receptors. Preliminary research indicates that derivatives of Triacetonamine may modulate the activity of serotonin and dopamine receptors, offering a possible avenue for treating neurological disorders such as depression and Parkinson's disease.
In conclusion, the multifaceted applications of Triacetonamine underscore its importance as a versatile intermediate in chemical synthesis. Its role in pharmaceutical research, particularly in the development of antibiotics, antivirals, and CNS drugs, highlights its significance in addressing global health challenges. As research continues to uncover new methodologies for functionalizing this compound, its potential applications are expected to expand further, solidifying its place as a cornerstone molecule in modern chemistry and medicine.
826-36-8 (Triacetonamine) Related Products
- 54156-50-2(9-Azabicyclo[3.3.1]nonan-3-one, 1,5,7-trimethyl-)
- 10581-38-1(2,2,6,6-Tetramethyl-4-piperidone monohydrate)
- 33973-59-0(2,2,6,6-Tetramethylpiperidin-4-one hydrochloride)
- 15486-23-4(9-Azabicyclo[3.3.1]nonan-3-one,1-methyl-, (1S,5R)-)
- 362053-34-7(6-azaspiro4.5decan-9-one)
- 52168-48-6(4-Oxo-2,2,6,6-tetramethylpiperidine-d17)
- 686778-07-4( )
- 77515-68-5(1-Azaspiro[5.5]undecan-8-one)
- 80404-11-1(4-oxo-2,2,6,6-tetramethylpiperidine (d17, 15n))
- 133568-79-3(2-Ethyl-2,6,6-trimethylpiperidin-4-one)